Argus downgraded Elevance Health (ELV) to Hold from Buy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health: Buy Rating Affirmed Amid Growth Potential in Non-HIX Segments and Temporary Earnings Boosts
- Insider Moves: Seagate, Elevance, Appian, AeroVironment, Box
- JPMorgan, Starbucks, HPE, Sarepta, Elevance: Trending by Analysts
- Elevance Health CEO Boudreaux buys $2.44M of shares
- Elevance Health falls -7.2%